VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,497,861 | -11.7% | 169,135 | -0.1% | 0.03% | -20.0% |
| Q2 2023 | $5,095,345 | -19.6% | 169,224 | -13.7% | 0.04% | -25.5% |
| Q1 2023 | $6,340,341 | +50.5% | 195,992 | +33.3% | 0.05% | +38.2% |
| Q4 2022 | $4,212,819 | -28.4% | 146,993 | -39.7% | 0.03% | -53.4% |
| Q3 2022 | $5,883,000 | -8.9% | 243,921 | +3.4% | 0.07% | -12.0% |
| Q2 2022 | $6,457,000 | +69.6% | 235,823 | +137.5% | 0.08% | +80.4% |
| Q1 2022 | $3,808,000 | +20.3% | 99,308 | +0.5% | 0.05% | +17.9% |
| Q4 2021 | $3,166,000 | +51.6% | 98,847 | +39.5% | 0.04% | +39.3% |
| Q3 2021 | $2,089,000 | -32.1% | 70,877 | -21.7% | 0.03% | -34.9% |
| Q2 2021 | $3,078,000 | +145.7% | 90,572 | +135.0% | 0.04% | +59.3% |
| Q1 2021 | $1,253,000 | -56.3% | 38,538 | -51.6% | 0.03% | -59.1% |
| Q4 2020 | $2,868,000 | -1.7% | 79,619 | +6.9% | 0.07% | -13.2% |
| Q3 2020 | $2,918,000 | -55.9% | 74,509 | -58.7% | 0.08% | -56.8% |
| Q2 2020 | $6,614,000 | +605.1% | 180,309 | +343.1% | 0.18% | +467.7% |
| Q1 2020 | $938,000 | -64.3% | 40,692 | -54.6% | 0.03% | -55.7% |
| Q4 2019 | $2,630,000 | -3.8% | 89,557 | -12.6% | 0.07% | -14.6% |
| Q3 2019 | $2,733,000 | +34.5% | 102,525 | +29.3% | 0.08% | +30.2% |
| Q2 2019 | $2,032,000 | -4.9% | 79,296 | -17.2% | 0.06% | -8.7% |
| Q1 2019 | $2,136,000 | +14.0% | 95,746 | +7.6% | 0.07% | -5.5% |
| Q4 2018 | $1,873,000 | +67.7% | 88,965 | +47.7% | 0.07% | +87.2% |
| Q3 2018 | $1,117,000 | +8.6% | 60,237 | +28.4% | 0.04% | -13.3% |
| Q1 2018 | $1,029,000 | -3.9% | 46,903 | +1.8% | 0.04% | 0.0% |
| Q4 2017 | $1,071,000 | +3.7% | 46,056 | +2.3% | 0.04% | -4.3% |
| Q3 2017 | $1,033,000 | -1.3% | 45,023 | -5.2% | 0.05% | -4.1% |
| Q2 2017 | $1,047,000 | -5.2% | 47,497 | -1.8% | 0.05% | -7.5% |
| Q1 2017 | $1,104,000 | +15.6% | 48,386 | +5.7% | 0.05% | +6.0% |
| Q4 2016 | $955,000 | +29.6% | 45,780 | +64.1% | 0.05% | +78.6% |
| Q3 2016 | $737,000 | +18.7% | 27,903 | +25.0% | 0.03% | -22.2% |
| Q2 2016 | $621,000 | – | 22,320 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |